General discussion, page-20225

Hi BreakingSystem
IMO opinion the break will be final FDA on commencement of TP3 once analytical data is in for correct dosing and safety reports.
With Dr Mark and BC in charge in this department where in good hand and very optimistic.

I looked at the RePosa name and the soft pill concept and threw around the idea to family, friends and general discussions when I was in Europe last year
The concept of taking an injection, soft cap or CPAP was an overwhelming big tick for a soft cap. Also being Latin based countries calling the name RePosa, meaning to rest, rejuvenate, sleep, reinvigorate had a huge appeal and could be the generic name people use to counter OSA.
I flagged this with management.
GL mate